Ligand Pharmaceuticals Inc (NASDAQ:LGND)

89.67
Delayed Data
As of May 22
 +0.44 / +0.49%
Today’s Change
41.99
Today|||52-Week Range
90.48
+68.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues30.0M31.4M49.0M64.5M
 
 
 
 
 
Cost of Goods Sold2.1M874.0K3.1M6.5M
 
 
 
 
 
Depreciation And Amortization2.8M2.7M2.7M2.7M
 
 
 
 
 
 
Operating ExpensesGross Income25.1M27.8M43.2M55.4M
 
 
 
 
 
General Expenses25.3M26.9M27.3M34.7M
 
 
 
 
 
Research And Development10.3M10.8M9.3M12.1M
 
 
 
 
 
Total Operating Expenses30.2M30.5M33.0M43.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-140.0K889.0K16.0M20.7M
 
 
 
 
 
Extraordinary Credit22.0K0.000.00544.0K
 
 
 
Extraordinary Charge-2.7M-2.0M-4.6M-6.8M
 
 
 
 
 
Interest Expense On Debt2.5M3.3M2.1M4.9M
 
 
 
 
 
Other Expenses2.3M516.0K-63.0K1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.0M-3.9M9.2M11.3M
 
 
 
 
 
Income Taxes-13.1M-1.2M-374.0K-410.0K
 
 
 
 
 
Minority Interest0.000.000.00-1.1M
 
 
Extraordinary Items3.0K2.1M2.6M0.00
 
 
 
 
Net Income10.2M-2.7M8.8M12.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS--19.9M20.3M20.4M
 
 
 
 
Shares To Calculate EPS Diluted--19.9M20.7M21.4M
 
 
 
 
 
Earnings Per ShareEPS$0.52-$0.03$0.55$0.56
 
 
 
 
 
EPS Diluted---$0.13$0.43$0.56
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account